Pharmabiz

US FDA approves Gamida Cell’s Omisirge, first cellular therapy to treat patients with severe aplastic anaemia

The US Food and Drug Administration (FDA) has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplant (HSCT) therapy to treat patients with severe aplastic anaemia (SAA).
Pharmabiz

Kiran Mazumdar-Shaw honoured with ‘USC Business Management Award’ for her contributions in global healthcare and biotechnology

Kiran Mazumdar-Shaw, founder and chairperson, Biocon Group has been honoured with the USC Business Management Award, at the inaugural University of Southern California (USC) India Awards. She received ...
Pharmabiz

Ceiling Price fixation or revision resulted in annual savings of Rs. 3,800 crore, says minister

Ceiling Price fixation or revision resulted in annual savings of Rs. 3,800 crore, says minister: Our Bureau, New Delhi Wednesday, December 10, 2025, 15:30 Hrs [IST] The National P ...
Pharmabiz

Researchers find genetic basis for important risk factor in blinding eye disease

Researchers find genetic basis for important risk factor in blinding eye disease: Bethesda, Maryland Wednesday, December 10, 2025, 15:30 Hrs [IST] A study funded in part by the Na ...
Pharmabiz

Zydus and Formycon partner for licensing and supply of biosimilar to Keytruda in US and Canada

Zydus and Formycon partner for licensing and supply of biosimilar to Keytruda in US and Canada: Our Bureau, Mumbai Wednesday, December 10, 2025, 15:20 Hrs [IST] Zydus Lifesciences ...
Pharmabiz

Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark

Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark: Basel Wednesday, December 10, 2025, 15:00 Hrs ...
Pharmabiz

Bristol Myers Squibb advances lymphoma research with new targeted protein degradation and cell therapy data at ASH 2025

Bristol Myers Squibb reinforces its haematology leadership through new research across multiple therapies for patients with lymphoma at the 67th American Society of Haematology (ASH) Annual Meeting.
Pharmabiz

Zydus introduces biosimilar denosumab 120 mg SC – protecting bone health in cancer patients

Zydus Lifesciences Ltd., an innovation-led healthcare company, with an international presence has launched ‘Zyrifa’, a denosumab biosimilar. Denosumab is a monoclonal antibody with several indications ...
Pharmabiz

Johns Hopkins University with Great Learning to launch AI in healthcare programme

Great Learning, a leading global edtech company, has launched the AI in healthcare programme in collaboration with Johns Hopkins University (JHU), a globally top-ranked university in medicine and ...
Pharmabiz

EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide

EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide: Providence, Rhode Island Wednesday, December 10, 2 ...
Pharmabiz

iPHEX 2026 stall bookings open as global pharma community gears up for 12th Edition

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has formally announced the opening of the stall retention and fresh booking process for iPHEX 2026, the 12th edition of the ...
Pharmabiz

Japan’s MHLW grants Pioneering Regenerative Medical Product Designation to AskBio’s AB-1005 and AB-1002

Japan’s MHLW grants Pioneering Regenerative Medical Product Designation to AskBio’s AB-1005 and AB-1002: Berlin, Germany Wednesday, December 10, 2025, 12:00 Hrs [IST] AskBio I ...